4 minute read
Aug. 26, 2022
"Compound 33" is a cGMP-Dependent Protein Kinase G1α (PKG1α) Activator
compound 33
intravenous PKG1α activator satisfactory in vivo rat PK profile from 2.9 M compounds HTS, SBDD and opt J. Med. Chem., July 25, 2022 Merck & Co., Inc., South San Francisco, CA